A Phase 4 interventional study of Viagra (Sildenafil citrate) in Impotence, sponsored by Pfizer's Upjohn has merged with Mylan to form Viatris Inc.. Completed at 27 sites in Canada. Open to male participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2021-02-01.
Sponsored by Pfizer's Upjohn has merged with Mylan to form Viatris Inc. (part of Viatris Inc.) · Phase 4, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 50 studies testing sildenafil in Erectile Dysfunction — 1 open to participants now, 1 under way, 1 of them phase 3. sildenafil · Erectile Dysfunction.
Among the 50 studies testing sildenafil in Erectile Dysfunction, this one is the 17th largest by enrollment, is one of 12 that started in 2005, is one of 30 in phase 4, and was the 15th registered.
702 studies on the registry are indexed under Erectile Dysfunction; 125 are open to participants now.
Browse Erectile Dysfunction studies →1 of the 50 studies testing sildenafil in Erectile Dysfunction is open now. Recruiting first, the newest first:
sildenafil: first FDA approval 1998 (VIAGRA), first EMA approval 1998. What it is approved for, and how studies give it, is on its page →
Of the 78 Erectile Dysfunction studies recruiting now, 31 (40%) set no upper age limit and 34 (44%) stop at 75 or younger; 2 take children under 18; 7 take healthy volunteers.
This study: 18 Years and older · male · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
50 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 7 · Phase 2 3 · Phase 3 6 · Phase 4 30
First in 2002; this study’s year is marked. 12 started in 2005.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 183 is above the median of 70 across 551 interventional studies indexed under Erectile Dysfunction.
Median enrollment 108 across the 50 interventional studies. Of the 38 that completed or were terminated, 6 (16%) have results posted.
This tab as a report to print or save as PDF → With an account.
32 of 50 have an industry lead sponsor. The 10 most frequent:
This study is registered under Pfizer's Upjohn has merged with Mylan to form Viatris Inc., one of the names counted as Viatris Inc.. Under that name alone:
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. is the lead sponsor of 434 studies on the registry; none are open to participants now.
Of its 9 completed or terminated interventional studies of FDA-regulated products, 8 (89%) have results posted.
27 studies in Erectile Dysfunction by Viatris Inc.: none open now, none under way, none of them phase 3. Of 27 finished, 5 (19%) have results posted.
Among the 27 studies in Erectile Dysfunction by Viatris Inc., this one is the 13th largest by enrollment of the 24 interventional ones that give a count, is one of 10 that started in 2005, is one of 19 in phase 4, and was the 12th registered.
Viatris Inc.’s Erectile Dysfunction studies by the year they started, since 2002.
None of the studies under way reaches primary completion within a year.
Among the 50 studies testing sildenafil in Erectile Dysfunction, from their registry updates:
Nothing recorded among them since 2026-09-25.
Among Viatris Inc.’s 27 in Erectile Dysfunction:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
Men's quality of life (QoL) is potentially affected by mild erectile dysfunction (ED) to the same extent as it is by moderate and severe ED. This study will provide controlled clinical data measuring efficacy, QoL parameters and satisfaction changes in men with mild ED treated with Viagra versus those treated with a placebo. With an open-label extension, this study will also provide all study subjects the opportunity to receive the active drug treatment for 6 weeks.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Erectile Dysfunction Inventory of Treatment Satisfaction (EDITS) Index at the End of the DB Treatment (Week 8)
adjusted mean : Possible scores for the EDITS Index range from 0 (extremely low treatment satisfaction) to 100 (extremely high treatment satisfaction).
Time frame: Week 8
Erectile Dysfunction Inventory of Treatment Satisfaction (EDITS) Index
Possible scores for the EDITS Index range from 0 (extremely low treatment satisfaction) to 100 (extremely high treatment satisfaction).
Time frame: Week 8, Week 14
Change From Baseline to End of Double-Blind Phase (Week 8) in Patient Reported Erectile Function Assessment (PREFA) Total Score
adjusted mean change; PREFA Total Score: 8 = worst; 32 = best.
Time frame: Week 8
Patient Reported Erectile Function Assessment (PREFA) Total Score
PREFA Total Score: 8 = worst, 32 = best.
Time frame: Week 8, Week 14
Change From Baseline to End of DB Phase (Week 8) in International Index of Erectile Function (IIEF) Domain Scores- Erectile Function
adjusted mean change - Possible total scores for IIEF-EF range from 1 (worst) to 30 (best).
Time frame: Week 8
Change From Baseline to End of DB Phase (Week 8) in International Index of Erectile Function (IIEF) Domain Scores- Orgasmic Function
adjusted mean change - Possible total scores for IIEF-OF range from 0 (worst) to 10 (best).
Time frame: Week 8
Change From Baseline to End of DB Phase (Week 8) in International Index of Erectile Function (IIEF) Domain Scores- Sexual Desire
adjusted mean change - Possible total scores for IIEF-SD range from 2 (worst) to 10 (best).
Time frame: Week 8
Change From Baseline to End of DB Phase (Week 8) in International Index of Erectile Function (IIEF) Domain Scores- Intercourse Satisfaction
adjusted mean - Possible total scores for IIEF-IS range from 0 (worst) to 15 (best).
Time frame: Week 8
Change From Baseline to End of DB Phase (Week 8) in International Index of Erectile Function (IIEF) Domain Scores- Overall Satisfaction
adjusted mean change - Possible total scores for IIEF-OS range from 2 (worst) to 10 (best).
Time frame: Week 8
International Index of Erectile Function (IIEF) Domain Scores- Erectile Function
Possible total scores for IIEF-EF range from 1 (worst) to 30 (best).
Time frame: Week 8, Week 14
International Index of Erectile Function (IIEF) Domain Scores- Orgasmic Function
Possible total scores for IIEF-OF range from 0 (worst) to 10 (best).
Time frame: Week 8, Week 14
International Index of Erectile Function (IIEF) Domain Scores- Sexual Desire
Possible total scores for IIEF-SD and IIEF-OS range from 2 (worst) to 10 (best).
Time frame: Week 8, Week 14
International Index of Erectile Function (IIEF) Domain Scores- Intercourse Satisfaction
Possible total scores for IIEF-IS range from 0 (worst) to 15 (best).
Time frame: Week 8, Week 14
International Index of Erectile Function (IIEF) Domain Scores- Overall Satisfaction
Possible total scores for IIEF-SD and IIEF-OS range from 2 (worst) to 10 (best).
Time frame: Week 8, Week 14
Change From Baseline to End of DB Phase (Week 8) in Erectile Distress Scale (EDS) Total Score
adjusted mean change - Possible total scores for EDS range from 5 (all of the time) to 30 (none of the time). Higher scores indicate less impact of ED.
Time frame: Week 8
Erectile Distress Scale (EDS) Total Score
Possible total scores for EDS range from 5 (all of the time) to 30 (none of the time). Higher scores indicate less impact of ED.
Time frame: Week 8, Week 14
Change From Baseline to End of DB Phase (Week 8) in Quality of Erection Questionnaire (QEQ) Total Score
adjusted mean change - QEQ raw total score (defined as the sum of scores from QEQ Questions 1 and 3 to 7 and ranged from 6 to 30) was transformed to QEQ total score on a scale of 0 (lowest) to 100 (highest).
Time frame: Week 8
Quality of Erection Questionnaire (QEQ) Total Score
QEQ raw total score (defined as the sum of scores from QEQ Questions 1 and 3 to 7 and ranged from 6 to 30) was transformed to QEQ total score on a scale of 0 (lowest) to 100 (highest).
Time frame: Week 8, Week 14
Global Efficacy Question 1 (GEQ1) Response at End of the Double-Blind Phase (Week 8) and at End of the Open-Label Phase (Week 14)
GEQ 1: Compared to having no treatment at all for your erection problem, has the medication you have been taking over the past 4 weeks improved your erections?Responder was defined as answering "Yes". % of responders/non-responders was calculated based on subjects who attempted intercourse.
Time frame: Week 8, Week 14
Global Efficacy Question 2 (GEQ2) Response at End of the Double-Blind Phase (Week 8) and at End of the Open-Label Phase (Week 14)
GEQ 2: Compared to having no treatment at all for your erection problem, has the medication you have been taking over the past 4 weeks improved your ability to have sexual intercourse? Responder was defined as answering "Yes". % of responders/non-responders was calculated based on subjects who attempted intercourse.
Time frame: Week 8, Week 14
Global Efficacy Question 3 (GEQ3) Response at End of the Double-Blind Phase (Week 8) and at End of the Open-Label Phase (Week 14)
GEQ 3: When you took a dose of study drug and had sexual stimulation, how often did you get an erection that allowed you to engage in satisfactory sexual intercourse? Resp. was defined as answering almost always or always, most times, or sometimes, and non-resp was defined as answering a few times or almost never or never.
Time frame: Week 8, Week 14
Percentage of Occasions of Successful Intercourse (Event Log)
Percentage of occasions at which subjects answered yes to the question, did your erection last long enough to have successful intercourse. Calculation for each subject for each event log endpoint: percentage = (number of occasions with an answer of 'Yes' within visit interval) / (number of occasions within visit interval) x 100.
Time frame: Baseline to Week 8
Percentage of Occasions of Ejaculation and/or Orgasm (Event Log)
Percentage of occasions at which subjects answered yes to the question, did your erection last long enough to have successful intercourse. Calculation for each subject for each event log endpoint: percentage = (number of occasions with an answer of 'Yes' within visit interval) / (number of occasions within visit interval) x 100.
Time frame: Baseline to Week 8
Percentage of Occasions of Successful Intercourse (Event Log)
Percentage of occasions at which subjects answered yes to the question, did your erection last long enough to have successful intercourse. Calculation for each subject for each event log endpoint: percentage = (number of occasions with an answer of 'Yes' within visit interval) / (number of occasions within visit interval) x 100.
Time frame: Week 8 to Week 14
Percentage of Occasions of Ejaculation and/or Orgasm Event Log
Percentage of occasions at which subjects answered yes to the question, did your erection last long enough to have successful intercourse. Calculation for each subject for each event log endpoint: percentage = (number of occasions with an answer of 'Yes' within visit interval) / (number of occasions within visit interval) x 100.
Time frame: Week 8 to Week 14
Change From Baseline to Week 8 in Analog Scales- Firmness
mean change - scale of 0 (worst) to 10 (best).
Time frame: baseline to Week 8
Change From Baseline to Week 8 in Analog Scales- Maintenance
mean change - scale of 0 (worst) to 10 (best).
Time frame: baseline to Week 8
Change From Baseline to Week 8 in Analog Scales- Reliability
mean change - scale of 0 (worst) to 10 (best).
Time frame: baseline to Week 8
Change From Baseline to Week 8 in Analog Scales- General Sexual Performance
mean change - scale of 0 (worst) to 10 (best)
Time frame: baseline to week 8
Analog Scales- Firmness
mean - scale of 0 (worst) to 10 (best)
Time frame: Week 8, Week 14
Analog Scales- Maintenance
mean - scale of 0 (worst) to 10 (best)
Time frame: Week 8, Week 14
Analog Scales- Reliability
mean - scale of 0 (worst) to 10 (best)
Time frame: Week 8, Week 14
Analog Scales- General Sexual Performance
mean - scale of 0 (worst) to 10 (best)
Time frame: Week 8, Week 14
Shift in Responder Rate From Week 8 to Week 14 for Global Efficacy Question (GEQ) 1
GEQ 1: Compared to having no treatment at all for your erection problem, has the medication you have been taking over the past 4 weeks improved your erections? Responder was defined as answering Yes to GEQ 1.
Time frame: Week 8 to Week 14
Shift in Responder Rate From Week 8 to Week 14 for GEQ2
GEQ 2: Compared to having no treatment at all for your erection problem, has the medication you have been taking over the past 4 weeks improved your ability to have sexual intercourse? Responder was defined as answering Yes to GEQ 2.
Time frame: Week 8 to Week 14
Shift in Responder Rate From Week 8 to Week 14 for GEQ3
GEQ3: When you took a dose of study drug and had sexual stimulation, how often did you get an erection that allowed you to engage in satisfactory sexual intercourse? Responder = almost always or always, most times, or sometimes. Non-responder = a few times (much less than half the time) or almost never or never.
Time frame: Week 8 to Week 14
Baseline to <Week 8 and Week 8 to <=Week 14 in Event Log: Hardness of First Erections Grade 0
Per-patient percentage of hardness of erections:Grade 0 = no erection at all. Calculation for each subject for each event log endpoint: percentage = (number of occasions with an answer of 'Yes' within visit interval) / (number of occasions within visit interval) x 100.
Time frame: Baseline to <Week 8 and Week 8 to <=Week 14
Baseline to <Week 8 and Week 8 to <=Week 14 in Event Log: Hardness of First Erections Grade 1
Per-patient percentage of hardness of erections: Grade 1 = increase in size but not hard. Calculation for each subject for each event log endpoint: percentage = (number of occasions with an answer of 'Yes' within visit interval) / (number of occasions within visit interval) x 100.
Time frame: Baseline to <= Week 14
Baseline to <Week 8 and Week 8 to <=Week 14 in Event Log: Hardness of First Erections Grade 2
Per-patient percentage of hardness of erections: Grade 2 = hard but not hard enough for penetration. Calculation for each subject for each event log endpoint: percentage = (number of occasions with an answer of 'Yes' within visit interval) / (number of occasions within visit interval) x 100.
Time frame: Baseline to <Week 8 and Week 8 to <=Week 14
Baseline to <Week 8 and Week 8 to <=Week 14 in Event Log: Hardness of First Erections Grade 3
Per-patient percentage of hardness of erections: Grade 3 = hard enough for penetration but not completely hard. Calculation for each subject for each event log endpoint: percentage = (number of occasions with an answer of 'Yes' within visit interval) / (number of occasions within visit interval) x 100.
Time frame: Baseline to <Week 8 and Week 8 to <=Week 14
Baseline to <Week 8 and Week 8 to <=Week 14 in Event Log: Hardness of First Erections Grade 4
Per-patient percentage of hardness of erections: Grade 4 = completely hard. Calculation for each subject for each event log endpoint: percentage = (number of occasions with an answer of 'Yes' within visit interval) / (number of occasions within visit interval) x 100.
Time frame: Baseline to <Week 8 and Week 8 to <=Week 14
Baseline to <Week 8 and Week 8 to <=Week 14 in Event Log: Hardness of First Erections Grade 3 or 4
Per-patient percentage of hardness of erections: Grade 3 = hard enough for penetration but not completely hard, Grade 4 = completely hard. Calculation for each subject for each event log endpoint: percentage = (number of occasions with an answer of 'Yes' within visit interval) / (number of occasions within visit interval) x 100.
Time frame: Baseline to <Week 8 and Week 8 to <=Week 14
Baseline to <Week 8 and Week 8 to <=Week 14 in Event Log: Hardness of Second Erections Grade 0
Per-patient percentage of hardness of second erections: Grade 0 = no erection at all. Calculation for each subject for each event log endpoint: percentage = (number of occasions with an answer of 'Yes' within visit interval) / (number of occasions within visit interval) x 100.
Time frame: Baseline to <Week 8 and Week 8 to <=Week 14
Baseline to <Week 8 and Week 8 to <=Week 14 in Event Log: Hardness of Second Erections Grade 1
Per-patient percentage of hardness of second erections: Grade 1 = increase in size but not hard. Calculation for each subject for each event log endpoint: percentage = (number of occasions with an answer of 'Yes' within visit interval) / (number of occasions within visit interval) x 100.
Time frame: Baseline to <Week 8 and Week 8 to <=Week 14
Baseline to <Week 8 and Week 8 to <=Week 14 in Event Log: Hardness of Second Erections Grade 2
Per-patient percentage of hardness of second erections:Grade 2 = hard but not hard enough for penetration. Calculation for each subject for each event log endpoint: percentage = (number of occasions with an answer of 'Yes' within visit interval) / (number of occasions within visit interval) x 100.
Time frame: Baseline to <Week 8 and Week 8 to <=Week 14
Baseline to <Week 8 and Week 8 to <=Week 14 in Event Log: Hardness of Second Erections Grade 3
Per-patient percentage of hardness of second erections:Grade 3 = hard enough for penetration but not completely hard. Calculation for each subject for each event log endpoint: percentage = (number of occasions with an answer of 'Yes' within visit interval) / (number of occasions within visit interval) x 100.
Time frame: Baseline to <Week 8 and Week 8 to <=Week 14
Baseline to <Week 8 and Week 8 to <=Week 14 in Event Log: Hardness of Second Erections Grade 4
Per-patient percentage of hardness of second erections:Grade 4 = completely hard. Calculation for each subject for each event log endpoint: percentage = (number of occasions with an answer of 'Yes' within visit interval) / (number of occasions within visit interval) x 100.
Time frame: Baseline to <Week 8 and Week 8 to <=Week 14
Baseline to <Week 8 and Week 8 to <=Week 14 in Event Log: Hardness of Second Erections Grade 3 or 4
Per-patient percentage of hardness of second erections: Grade 3 = hard enough for penetration but not completely hard, Grade 4 = completely hard. Calculation for each subject for each event log endpoint: percentage = (number of occasions with an answer of 'Yes' within visit interval) / (number of occasions within visit interval) x 100.
Time frame: Baseline to <Week 8 and Week 8 to <=Week 14
Baseline to <Week 8 and Week 8 to <=Week 14 in Event Log: Frequency of Second Erections
Percentage of occasions at which second erection was achieved. Calculation for each subject for each event log endpoint: percentage = (number of occasions with an answer of 'Yes' within visit interval) / (number of occasions within visit interval) x 100.
Time frame: Baseline to <Week 8 and Week 8 to <=Week 14
31 centers in Canada
| Milestone | DB Viagra / OL Viagra | DB Placebo/OL Viagra |
|---|---|---|
| Started | 94 | 82 |
| Completed | 84 | 69 |
| Not completed | 10 | 13 |
| Withdrew: Adverse event | 1 | 0 |
| Withdrew: Lack of efficacy | 0 | 1 |
| Withdrew: Lost to follow-up | 3 | 3 |
| Withdrew: Withdrawal by subject | 5 | 5 |
| Withdrew: Other | 1 | 4 |
| Milestone | DB Viagra / OL Viagra | DB Placebo/OL Viagra |
|---|---|---|
| Started | 83 | 69 |
| Completed | 79 | 67 |
| Not completed | 4 | 2 |
| Withdrew: Adverse event | 1 | 0 |
| Withdrew: Lost to follow-up | 1 | 2 |
| Withdrew: Other | 2 | 0 |
adjusted mean : Possible scores for the EDITS Index range from 0 (extremely low treatment satisfaction) to 100 (extremely high treatment satisfaction).
| scores on a scale | DB Viagra | DB Placebo |
|---|---|---|
| Erectile Dysfunction Inventory of Treatment Satisfaction (EDITS) Index at the End of the DB Treatment (Week 8) | 80.27 ± 2.329 | 62.15 ± 2.524 |
Possible scores for the EDITS Index range from 0 (extremely low treatment satisfaction) to 100 (extremely high treatment satisfaction).
| scores on a scale | DB Viagra Week 8 | DB Viagra/OL Viagra Week 14 | DB Placebo Week 8 | DB Placebo/OL Viagra Week 14 |
|---|---|---|---|---|
| Erectile Dysfunction Inventory of Treatment Satisfaction (EDITS) Index | 79.21 ± 19.646 | 84.12 ± 17.220 | 61.64 ± 22.752 | 87.42 ± 15.124 |
adjusted mean change; PREFA Total Score: 8 = worst; 32 = best.
| scores on a scale | DB Viagra | DB Placebo |
|---|---|---|
| Change From Baseline to End of Double-Blind Phase (Week 8) in Patient Reported Erectile Function Assessment (PREFA) Total Score | 3.97 ± 0.498 | 2.21 ± 0.536 |
PREFA Total Score: 8 = worst, 32 = best.
| scores on a scale | DB Viagra Week 8 | DB Viagra /OL Viagra Week 14 | DB Placebo Week 8 | DB Placebo/OL Viagra Week 14 |
|---|---|---|---|---|
| Patient Reported Erectile Function Assessment (PREFA) Total Score | 28.54 ± 3.468 | 29.58 ± 2.988 | 26.79 ± 3.753 | 29.73 ± 2.895 |
adjusted mean change - Possible total scores for IIEF-EF range from 1 (worst) to 30 (best).
| scores on a scale | DB Viagra | DB Placebo |
|---|---|---|
| Change From Baseline to End of DB Phase (Week 8) in International Index of Erectile Function (IIEF) Domain Scores- Erectile Function | 2.08 ± 0.642 | -0.53 ± 0.698 |
adjusted mean change - Possible total scores for IIEF-OF range from 0 (worst) to 10 (best).
| scores on a scale | DB Viagra | DB Placebo |
|---|---|---|
| Change From Baseline to End of DB Phase (Week 8) in International Index of Erectile Function (IIEF) Domain Scores- Orgasmic Function | 0.59 ± 0.248 | 0.30 ± 0.271 |
adjusted mean change - Possible total scores for IIEF-SD range from 2 (worst) to 10 (best).
| scores on a scale | DB Viagra | DB Placebo |
|---|---|---|
| Change From Baseline to End of DB Phase (Week 8) in International Index of Erectile Function (IIEF) Domain Scores- Sexual Desire | 0.60 ± 0.207 | -0.08 ± 0.223 |
adjusted mean - Possible total scores for IIEF-IS range from 0 (worst) to 15 (best).
| scores on a scale | DB Viagra | DB Placebo |
|---|---|---|
| Change From Baseline to End of DB Phase (Week 8) in International Index of Erectile Function (IIEF) Domain Scores- Intercourse Satisfaction | 2.20 ± 0.365 | 1.00 ± 0.390 |
adjusted mean change - Possible total scores for IIEF-OS range from 2 (worst) to 10 (best).
| scores on a scale | DB Viagra | DB Placebo |
|---|---|---|
| Change From Baseline to End of DB Phase (Week 8) in International Index of Erectile Function (IIEF) Domain Scores- Overall Satisfaction | 2.35 ± 0.254 | 1.46 ± 0.275 |
Possible total scores for IIEF-EF range from 1 (worst) to 30 (best).
| scores on a scale | DB Viagra Week 8 | DB Viagra/OL Viagra Week 14 | DB Placebo Week 8 | DB Placebo/OL Viagra Week 14 |
|---|---|---|---|---|
| International Index of Erectile Function (IIEF) Domain Scores- Erectile Function | 24.92 ± 5.375 | 26.43 ± 5.023 | 22.40 ± 6.403 | 27.67 ± 3.573 |
Possible total scores for IIEF-OF range from 0 (worst) to 10 (best).
| scores on a scale | DB Viagra Week 8 | DB Viagra/OL Viagra Week 14 | DB Placebo Week 8 | DB Placebo/OL Viagra Week 14 |
|---|---|---|---|---|
| International Index of Erectile Function (IIEF) Domain Scores- Orgasmic Function | 8.62 ± 1.812 | 8.95 ± 1.598 | 7.81 ± 2.564 | 9.21 ± 1.213 |
Possible total scores for IIEF-SD and IIEF-OS range from 2 (worst) to 10 (best).
| scores on a scale | DB Viagra Week 8 | DB Viagra/OL Viagra Week 14 | DB Placebo Week 8 | DB Placebo/OL Viagra Week 14 |
|---|---|---|---|---|
| International Index of Erectile Function (IIEF) Domain Scores- Sexual Desire | 7.90 ± 1.665 | 8.10 ± 1.539 | 7.37 ± 1.712 | 8.18 ± 1.230 |
Possible total scores for IIEF-IS range from 0 (worst) to 15 (best).
| scores on a scale | DB Viagra Week 8 | DB Viagra/OL Viagra Week 14 | DB Placebo Week 8 | DB Placebo/OL Viagra Week 14 |
|---|---|---|---|---|
| International Index of Erectile Function (IIEF) Domain Scores- Intercourse Satisfaction | 11.82 ± 2.806 | 12.64 ± 2.367 | 10.84 ± 2.635 | 13.12 ± 1.943 |
Possible total scores for IIEF-SD and IIEF-OS range from 2 (worst) to 10 (best).
| scores on a scale | DB Viagra Week 8 | DB Viagra/OL Viagra Week 14 | DB Placebo Week 8 | DB Placebo/OL Viagra Week 14 |
|---|---|---|---|---|
| International Index of Erectile Function (IIEF) Domain Scores- Overall Satisfaction | 8.19 ± 1.827 | 8.94 ± 1.656 | 7.25 ± 2.178 | 9.12 ± 1.332 |
adjusted mean change - Possible total scores for EDS range from 5 (all of the time) to 30 (none of the time). Higher scores indicate less impact of ED.
| scores on a scale | DB Viagra | DB Placebo |
|---|---|---|
| Change From Baseline to End of DB Phase (Week 8) in Erectile Distress Scale (EDS) Total Score | 5.14 ± 0.870 | 2.36 ± 0.926 |
Possible total scores for EDS range from 5 (all of the time) to 30 (none of the time). Higher scores indicate less impact of ED.
| scores on a scale | DB Viagra Week 8 | DB Viagra/OL Viagra Week 14 | DB Placebo Week 8 | DB Placebo/OL Viagra Week 14 |
|---|---|---|---|---|
| Erectile Distress Scale (EDS) Total Score | 24.58 ± 6.039 | 24.55 ± 6.552 | 21.23 ± 6.246 | 26.58 ± 4.717 |
adjusted mean change - QEQ raw total score (defined as the sum of scores from QEQ Questions 1 and 3 to 7 and ranged from 6 to 30) was transformed to QEQ total score on a scale of 0 (lowest) to 100 (highest).
| scores on a scale | DB Viagra | DB Placebo |
|---|---|---|
| Change From Baseline to End of DB Phase (Week 8) in Quality of Erection Questionnaire (QEQ) Total Score | 24.04 ± 3.260 | 5.62 ± 3.558 |
QEQ raw total score (defined as the sum of scores from QEQ Questions 1 and 3 to 7 and ranged from 6 to 30) was transformed to QEQ total score on a scale of 0 (lowest) to 100 (highest).
| scores on a scale | DB Viagra Week 8 | DB Viagra/OL Viagra Week 14 | DB Placebo Week 8 | DB Placebo/OL Viagra Week 14 |
|---|---|---|---|---|
| Quality of Erection Questionnaire (QEQ) Total Score | 80.20 ± 23.954 | 86.46 ± 20.918 | 63.64 ± 28.559 | 89.74 ± 17.473 |
GEQ 1: Compared to having no treatment at all for your erection problem, has the medication you have been taking over the past 4 weeks improved your erections?Responder was defined as answering "Yes". % of responders/non-responders was calculated based on subjects who attempted intercourse.
| percentage of subjects | Week 8 DB Viagra | Week 8 DB Placebo | Week 14 DB Viagra/OL Viagra | Week 14 DB Placebo/OL Viagra |
|---|---|---|---|---|
| GEQ1 Responder | 81.8 | 43.8 | 90.0 | 94.0 |
| GEQ1 Non-Responder | 18.2 | 56.2 | 10.0 | 6.0 |
GEQ 2: Compared to having no treatment at all for your erection problem, has the medication you have been taking over the past 4 weeks improved your ability to have sexual intercourse? Responder was defined as answering "Yes". % of responders/non-responders was calculated based on subjects who attempted intercourse.
| percentage of subjects | Week 8 DB Viagra | Week 8 DB Placebo | Week 14 DB Viagra/OL Viagra | Week 14 DB Placebo/OL Viagra |
|---|---|---|---|---|
| GEQ2 Responder | 79.3 | 45.2 | 86.3 | 92.5 |
| GEQ2 Non-Responder | 20.7 | 54.8 | 13.8 | 7.5 |
GEQ 3: When you took a dose of study drug and had sexual stimulation, how often did you get an erection that allowed you to engage in satisfactory sexual intercourse? Resp. was defined as answering almost always or always, most times, or sometimes, and non-resp was defined as answering a few times or almost never or never.
| percentage of subjects | Week 8 DB Viagra | Week 8 DB Placebo | Week 14 DB Viagra/OL Viagra | Week 14 DB Placebo/OL Viagra |
|---|---|---|---|---|
| GEQ3 Responders | 94.3 | 81.7 | 95.0 | 98.5 |
| GEQ3 Non-Responders | 5.7 | 18.3 | 5.0 | 1.5 |
Percentage of occasions at which subjects answered yes to the question, did your erection last long enough to have successful intercourse. Calculation for each subject for each event log endpoint: percentage = (number of occasions with an answer of 'Yes' within visit interval) / (number of occasions within visit interval) x 100.
| percentage of occasions | DB Viagra | DB Placebo |
|---|---|---|
| Percentage of Occasions of Successful Intercourse (Event Log) | 73.64 ± 26.689 | 59.73 ± 33.332 |
Percentage of occasions at which subjects answered yes to the question, did your erection last long enough to have successful intercourse. Calculation for each subject for each event log endpoint: percentage = (number of occasions with an answer of 'Yes' within visit interval) / (number of occasions within visit interval) x 100.
| Percentage of occasions | DB Viagra | DB Placebo |
|---|---|---|
| Percentage of Occasions of Ejaculation and/or Orgasm (Event Log) | 74.31 ± 25.300 | 64.60 ± 31.903 |
Percentage of occasions at which subjects answered yes to the question, did your erection last long enough to have successful intercourse. Calculation for each subject for each event log endpoint: percentage = (number of occasions with an answer of 'Yes' within visit interval) / (number of occasions within visit interval) x 100.
| percentage of occasions | DB Viagra / OL Viagra | DB Placebo/OL Viagra |
|---|---|---|
| Percentage of Occasions of Successful Intercourse (Event Log) | 79.65 ± 25.309 | 87.63 ± 21.936 |
Percentage of occasions at which subjects answered yes to the question, did your erection last long enough to have successful intercourse. Calculation for each subject for each event log endpoint: percentage = (number of occasions with an answer of 'Yes' within visit interval) / (number of occasions within visit interval) x 100.
| percentage of occasions | DB Viagra / OL Viagra | DB Placebo/OL Viagra |
|---|---|---|
| Percentage of Occasions of Ejaculation and/or Orgasm Event Log | 77.69 ± 25.099 | 85.29 ± 22.257 |
mean change - scale of 0 (worst) to 10 (best).
| units on a scale | DB Viagra | DB Placebo |
|---|---|---|
| Change From Baseline to Week 8 in Analog Scales- Firmness | 1.55 ± 2.023 | 0.38 ± 1.800 |
mean change - scale of 0 (worst) to 10 (best).
| units on a scale | DB Viagra | DB Placebo |
|---|---|---|
| Change From Baseline to Week 8 in Analog Scales- Maintenance | 1.84 ± 2.421 | 0.40 ± 2.152 |
mean change - scale of 0 (worst) to 10 (best).
| units on a scale | DB Viagra | DB Placebo |
|---|---|---|
| Change From Baseline to Week 8 in Analog Scales- Reliability | 1.61 ± 2.795 | 0.42 ± 2.081 |
mean change - scale of 0 (worst) to 10 (best)
| units on a scale | DB Viagra | DB Placebo |
|---|---|---|
| Change From Baseline to Week 8 in Analog Scales- General Sexual Performance | 1.72 ± 2.355 | 0.51 ± 2.109 |
mean - scale of 0 (worst) to 10 (best)
| units on a scale | DB Viagra Week 8 | DB Viagra/OL Viagra Week 14 | DB Placebo Week 8 | DB Placebo/OL Viagra Week 14 |
|---|---|---|---|---|
| Analog Scales- Firmness | 7.87 ± 1.872 | 8.25 ± 1.932 | 6.60 ± 2.171 | 8.64 ± 1.264 |
mean - scale of 0 (worst) to 10 (best)
| units on a scale | DB Viagra Week 8 | DB Viagra/OL Viagra Week 14 | DB Placebo Week 8 | DB Placebo/OL Viagra Week 14 |
|---|---|---|---|---|
| Analog Scales- Maintenance | 7.65 ± 2.138 | 8.01 ± 2.155 | 5.99 ± 2.519 | 8.55 ± 1.617 |
mean - scale of 0 (worst) to 10 (best)
| units on a scale | DB Viagra Week 8 | DB Viagra/OL Viagra Week 14 | DB Placebo Week 8 | DB Placebo/OL Viagra Week 14 |
|---|---|---|---|---|
| Analog Scales- Reliability | 7.35 ± 2.360 | 7.96 ± 2.292 | 6.04 ± 2.306 | 8.55 ± 1.550 |
mean - scale of 0 (worst) to 10 (best)
| units on a scale | DB Viagra Week 8 | DB Viagra/OL Viagra Week 14 | DB Placebo Week 8 | DB Placebo/OL Viagra Week 14 |
|---|---|---|---|---|
| Analog Scales- General Sexual Performance | 7.58 ± 2.077 | 8.01 ± 1.978 | 6.53 ± 2.128 | 8.49 ± 1.319 |
GEQ 1: Compared to having no treatment at all for your erection problem, has the medication you have been taking over the past 4 weeks improved your erections? Responder was defined as answering Yes to GEQ 1.
| subjects | DB Viagra / OL Viagra | DB Placebo/ OL Viagra |
|---|---|---|
| Responder at Week 8 / Responder at Week 14 | 61 | 27 |
| Responder at Week 8 / Non-Responder at Week 14 | 3 | 0 |
| Non-Responder at Week 8 / Responder at Week 14 | 11 | 36 |
| Non-Responder at Week 8 / Non-Responder at Week 14 | 5 | 4 |
GEQ 2: Compared to having no treatment at all for your erection problem, has the medication you have been taking over the past 4 weeks improved your ability to have sexual intercourse? Responder was defined as answering Yes to GEQ 2.
| subjects | DB Viagra / OL Viagra | DB Placebo / OL Viagra |
|---|---|---|
| Responder at Week 8 / Responder at Week 14 | 60 | 29 |
| Responder at Week 8 / Non-Responder at Week 14 | 1 | 0 |
| Non-Responder at Week 8 / Responder at Week 14 | 8 | 33 |
| Non-Responder at Week 8 / Non-Responder at Week 14 | 10 | 5 |
GEQ3: When you took a dose of study drug and had sexual stimulation, how often did you get an erection that allowed you to engage in satisfactory sexual intercourse? Responder = almost always or always, most times, or sometimes. Non-responder = a few times (much less than half the time) or almost never or never.
| subjects | DB Viagra / OL Viagra | DB Placebo / OL Viagra |
|---|---|---|
| Responder at Week 8 / Responder at Week 14 | 74 | 54 |
| Responder at Week 8 / Non-Responder at Week 14 | 0 | 0 |
| Non-Responder at Week 8 / Responder at Week 14 | 1 | 10 |
| Non-Responder at Week 8 / Non-Responder at Week 14 | 4 | 1 |
Per-patient percentage of hardness of erections:Grade 0 = no erection at all. Calculation for each subject for each event log endpoint: percentage = (number of occasions with an answer of 'Yes' within visit interval) / (number of occasions within visit interval) x 100.
| percentage of occasions | DB Viagra Baseline < Week 8 | DB Placebo Baseline to < Week 8 | DB Viagra/OL Viagra Week 8 to <=Week 14 | DB Placebo/OL Viagra Week 8 to <=Week 14 |
|---|---|---|---|---|
| Baseline to <Week 8 and Week 8 to <=Week 14 in Event Log: Hardness of First Erections Grade 0 | 7.09 ± 13.041 | 12.64 ± 23.834 | 4.50 ± 12.217 | 3.12 ± 9.855 |
Per-patient percentage of hardness of erections: Grade 1 = increase in size but not hard. Calculation for each subject for each event log endpoint: percentage = (number of occasions with an answer of 'Yes' within visit interval) / (number of occasions within visit interval) x 100.
| percentage of occasions | DB Viagra Baseline < Week 8 | DB Placebo Baseline < Week 8 | DB Viagra/OL Viagra Week 8 to <=Week 14 | DB Placebo/OL Viagra Week 8 to <=Week 14 |
|---|---|---|---|---|
| Baseline to <Week 8 and Week 8 to <=Week 14 in Event Log: Hardness of First Erections Grade 1 | 3.83 ± 9.600 | 6.31 ± 15.144 | 3.48 ± 14.300 | 1.88 ± 8.269 |
Per-patient percentage of hardness of erections: Grade 2 = hard but not hard enough for penetration. Calculation for each subject for each event log endpoint: percentage = (number of occasions with an answer of 'Yes' within visit interval) / (number of occasions within visit interval) x 100.
| percentage of occasions | DB Viagra Baseline < Week 8 | DB Placebo Baseline < Week 8 | DB Viagra/OL Viagra Week 8 to <=Week 14 | DB Placebo/OL Viagra Week 8 to <=Week 14 |
|---|---|---|---|---|
| Baseline to <Week 8 and Week 8 to <=Week 14 in Event Log: Hardness of First Erections Grade 2 | 6.96 ± 11.858 | 8.72 ± 15.190 | 4.62 ± 10.038 | 2.26 ± 7.813 |
Per-patient percentage of hardness of erections: Grade 3 = hard enough for penetration but not completely hard. Calculation for each subject for each event log endpoint: percentage = (number of occasions with an answer of 'Yes' within visit interval) / (number of occasions within visit interval) x 100.
| percentage of occasions | DB Viagra Baseline < Week 8 | DB Placebo Baseline < Week 8 | DB Viagra/OL Viagra Week 8 to <=Week 14 | DB Placebo/OL Viagra Week 8 to <=Week 14 |
|---|---|---|---|---|
| Baseline to <Week 8 and Week 8 to <=Week 14 in Event Log: Hardness of First Erections Grade 3 | 34.94 ± 29.253 | 47.17 ± 32.167 | 29.50 ± 28.515 | 30.12 ± 31.412 |
Per-patient percentage of hardness of erections: Grade 4 = completely hard. Calculation for each subject for each event log endpoint: percentage = (number of occasions with an answer of 'Yes' within visit interval) / (number of occasions within visit interval) x 100.
| percentage of occasions | DB Viagra Baseline < Week 8 | DB Placebo Baseline < Week 8 | DB Viagra/OL Viagra Week 8 to <=Week 14 | DB Placebo/OL Viagra Week 8 to <=Week 14 |
|---|---|---|---|---|
| Baseline to <Week 8 and Week 8 to <=Week 14 in Event Log: Hardness of First Erections Grade 4 | 47.19 ± 35.293 | 25.16 ± 33.764 | 57.89 ± 35.934 | 62.63 ± 35.112 |
Per-patient percentage of hardness of erections: Grade 3 = hard enough for penetration but not completely hard, Grade 4 = completely hard. Calculation for each subject for each event log endpoint: percentage = (number of occasions with an answer of 'Yes' within visit interval) / (number of occasions within visit interval) x 100.
| percentage of occasions | DB Viagra Baseline < Week 8 | DB Placebo Baseline < Week 8 | DB Viagra/OL Viagra Week 8 to <=Week 14 | DB Placebo/OL Viagra Week 8 to <=Week 14 |
|---|---|---|---|---|
| Baseline to <Week 8 and Week 8 to <=Week 14 in Event Log: Hardness of First Erections Grade 3 or 4 | 82.13 ± 23.476 | 72.33 ± 31.798 | 87.39 ± 22.496 | 92.75 ± 15.386 |
Per-patient percentage of hardness of second erections: Grade 0 = no erection at all. Calculation for each subject for each event log endpoint: percentage = (number of occasions with an answer of 'Yes' within visit interval) / (number of occasions within visit interval) x 100.
| percentage of occasions | DB Viagra Baseline < Week 8 | DB Placebo Baseline < Week 8 | DB Viagra/OL Viagra Week 8 to <=Week 14 | DB Placebo/OL Viagra Week 8 to <=Week 14 |
|---|---|---|---|---|
| Baseline to <Week 8 and Week 8 to <=Week 14 in Event Log: Hardness of Second Erections Grade 0 | 0.00 ± 0.000 | 3.18 ± 15.052 | 0.13 ± 0.985 | 2.17 ± 14.014 |
Per-patient percentage of hardness of second erections: Grade 1 = increase in size but not hard. Calculation for each subject for each event log endpoint: percentage = (number of occasions with an answer of 'Yes' within visit interval) / (number of occasions within visit interval) x 100.
| percentage of occasions | DB Viagra Baseline < Week 8 | DB Placebo Baseline < Week 8 | DB Viagra/OL Viagra Week 8 to <=Week 14 | DB Placebo/OL Viagra Week 8 to <=Week 14 |
|---|---|---|---|---|
| Baseline to <Week 8 and Week 8 to <=Week 14 in Event Log: Hardness of Second Erections Grade 1 | 6.43 ± 22.211 | 7.47 ± 22.317 | 1.70 ± 9.143 | 2.03 ± 8.638 |
Per-patient percentage of hardness of second erections:Grade 2 = hard but not hard enough for penetration. Calculation for each subject for each event log endpoint: percentage = (number of occasions with an answer of 'Yes' within visit interval) / (number of occasions within visit interval) x 100.
| percentage of occasions | DB Viagra Baseline < Week 8 | DB Placebo Baseline < Week 8 | DB Viagra/OL Viagra Week 8 to <=Week 14 | DB Placebo/OL Viagra Week 8 to <=Week 14 |
|---|---|---|---|---|
| Baseline to <Week 8 and Week 8 to <=Week 14 in Event Log: Hardness of Second Erections Grade 2 | 14.93 ± 28.145 | 15.27 ± 30.431 | 11.96 ± 24.555 | 12.66 ± 28.294 |
Per-patient percentage of hardness of second erections:Grade 3 = hard enough for penetration but not completely hard. Calculation for each subject for each event log endpoint: percentage = (number of occasions with an answer of 'Yes' within visit interval) / (number of occasions within visit interval) x 100.
| percentage of occasions | DB Viagra Baseline < Week 8 | DB Placebo Baseline < Week 8 | DB Viagra/OL Viagra Week 8 to <=Week 14 | DB Placebo/OL Viagra Week 8 to <=Week 14 |
|---|---|---|---|---|
| Baseline to <Week 8 and Week 8 to <=Week 14 in Event Log: Hardness of Second Erections Grade 3 | 37.41 ± 38.658 | 47.59 ± 41.025 | 42.97 ± 38.322 | 33.29 ± 31.633 |
Per-patient percentage of hardness of second erections:Grade 4 = completely hard. Calculation for each subject for each event log endpoint: percentage = (number of occasions with an answer of 'Yes' within visit interval) / (number of occasions within visit interval) x 100.
| percentage of occasions | DB Viagra Baseline < Week 8 | DB Placebo Baseline < Week 8 | DB Viagra/OL Viagra Week 8 to <=Week 14 | DB Placebo/OL Viagra Week 8 to <=Week 14 |
|---|---|---|---|---|
| Baseline to <Week 8 and Week 8 to <=Week 14 in Event Log: Hardness of Second Erections Grade 4 | 41.23 ± 41.013 | 26.49 ± 34.300 | 43.24 ± 39.891 | 49.86 ± 36.921 |
Per-patient percentage of hardness of second erections: Grade 3 = hard enough for penetration but not completely hard, Grade 4 = completely hard. Calculation for each subject for each event log endpoint: percentage = (number of occasions with an answer of 'Yes' within visit interval) / (number of occasions within visit interval) x 100.
| percentage of occasions | DB Viagra Baseline < Week 8 | DB Placebo Baseline < Week 8 | DB Viagra/OL Viagra Week 8 to <=Week 14 | DB Placebo/OL Viagra Week 8 to <=Week 14 |
|---|---|---|---|---|
| Baseline to <Week 8 and Week 8 to <=Week 14 in Event Log: Hardness of Second Erections Grade 3 or 4 | 78.64 ± 35.395 | 74.08 ± 40.922 | 86.21 ± 27.647 | 83.14 ± 31.561 |
Percentage of occasions at which second erection was achieved. Calculation for each subject for each event log endpoint: percentage = (number of occasions with an answer of 'Yes' within visit interval) / (number of occasions within visit interval) x 100.
| percentage of occasions | DB Viagra Baseline < Week 8 | DB Placebo Baseline < Week 8 | DB Viagra/OL Viagra Week 8 to <=Week 14 | DB Placebo/OL Viagra Week 8 to <=Week 14 |
|---|---|---|---|---|
| Baseline to <Week 8 and Week 8 to <=Week 14 in Event Log: Frequency of Second Erections | 38.06 ± 33.287 | 19.20 ± 28.977 | 44.07 ± 38.632 | 39.15 ± 37.159 |
| Age, Continuous(years) | Start : DB Viagra | Start : DB Placebo | Total |
|---|---|---|---|
| Mean | 51.6 ± 12.5 | 48.0 ± 11.9 | 49.9 ± 12.3 |
| Sex: Female, Male(Participants) | Start : DB Viagra | Start : DB Placebo | Total |
|---|---|---|---|
| Female | 0 | 0 | 0 |
| Male | 94 | 82 | 176 |
The record gives a start of Nov 2005, a primary completion of Sep 2007 and a completion of Sep 2007. It does not say whether these dates are actual or estimated.
Results were first posted in Dec 2008, 1 year 3 months after primary completion.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Jan 2021. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Sildenafil
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. →